MeiraGTx has struck a deal with Hologen Limited, an artificial intelligence (AI) company specialising in multimodal ...

To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Gene therapy specialist MeiraGTx ...

Damian Lewis cosied up to girlfriend Alison Mosshart at Masterpiece's Wolf Hall: The Mirror and the Light special screening ...

In comes, DeepSeek, a Chinese AI startup that has shown it is possible to develop AI models without spending much. It ...

RBC Capital raised the firm’s price target on MeiraGTx (MGTX) to $13 from $11 and keeps an Outperform rating on the shares after its Q4 ...

With MeiraGTx eyeing up how to take the drug through phase 3 and onto commercialization, Hologen has stepped in. The ...

Joint venture, Hologen Neuro AI, will expedite Phase 3 development of AAV-GAD for Parkinson’s Disease and industrialize ...

Evercore ISI analyst Gavin Clark-Gartner maintained a Buy rating on Meiragtx Holdings (MGTX – Research Report) on March 14 and set a price ...

MeiraGTx and Hologen form a neuro-AI drug development joint venture, with up to $430M in funding to advance Parkinson's and CNS treatments.

MeiraGTx (NASDAQ:MGTX – Get Free Report) will likely be releasing its earnings data before the market opens on Thursday, ...

MeiraGTx (MGTX) stock gains as the company teams up with Hologen to form a JV to advance gene therapies for Parkinson's and other CNS diseases. Read more here.

MeiraGTx (NASDAQ:MGTX – Get Free Report) had its price objective raised by Royal Bank of Canada from $11.00 to $13.00 in a research note issued on Monday,Benzinga reports.The brokerage currently ...